Difficulty: Medium
Average Score: 89%
Practice
Strong anticholinergic effects limit the antiarrhythmic use of
Correct answer
C
Rationale
The correct answer is C) Disopyramide. Disopyramide is a Class Ia antiarrhythmic drug that exhibits strong anticholinergic effects, which can lead to adverse effects such as dry mouth, blurred vision, urinary retention, and constipation. These anticholinergic effects can limit its use in patients, especially those with underlying conditions such as glaucoma, benign prostatic hyperplasia, or myasthenia gravis.
A) Quinidine is a Class Ia antiarrhythmic drug that can cause cinchonism (side effects like tinnitus and blurred vision) but does not have significant anticholinergic effects.
B) Procainamide is also a Class Ia antiarrhythmic drug that does not have strong anticholinergic effects, making it a safer choice compared to Disopyramide in patients who are sensitive to anticholinergic side effects.
D) Flecainide is a Class Ic antiarrhythmic drug that does not possess anticholinergic properties and is not associated with the same limitations as Disopyramide.
Understanding the specific side effect profiles of different antiarrhythmic drugs is crucial for healthcare providers to make informed decisions when selecting the most appropriate medication for individual patients. This knowledge helps in optimizing treatment outcomes while minimizing potential adverse effects and drug interactions.
A) Quinidine is a Class Ia antiarrhythmic drug that can cause cinchonism (side effects like tinnitus and blurred vision) but does not have significant anticholinergic effects.
B) Procainamide is also a Class Ia antiarrhythmic drug that does not have strong anticholinergic effects, making it a safer choice compared to Disopyramide in patients who are sensitive to anticholinergic side effects.
D) Flecainide is a Class Ic antiarrhythmic drug that does not possess anticholinergic properties and is not associated with the same limitations as Disopyramide.
Understanding the specific side effect profiles of different antiarrhythmic drugs is crucial for healthcare providers to make informed decisions when selecting the most appropriate medication for individual patients. This knowledge helps in optimizing treatment outcomes while minimizing potential adverse effects and drug interactions.